Canton, Massachusetts
United States
38
2024-06-13
The entities that hold a legal rights for patent applications filed by inventor Borodic Gary E.:
Gary E. Borodic from Canton, US has applied for patents for these inventions. The list has both pending applications and granted patents:
Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
#2 | 2024-04-04Methods of Treating a Spastic Disorder in a Subject Having Underlying Condition(s)
#3 | 2024-03-28Methods of Treating an Optic Disease in a Subject
#4 | 2024-01-04Methods of Treating or Preventing Migraine or Repetitive Occurrence of Common Migraine Headaches in a Subject Having Underlying Condition(s)
#5 | 2023-12-07Methods of Treating Cervical Dystonia in a Subject Having Underlying Condition(s)
#6 | 2021-10-07BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT
#7 | 2021-09-16BOTULINUM TOXIN AND THE TREATMENT OF PRIMARY DISORDERS OF MOOD AND AFFECT
#8 | 2021-08-19Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#9 | 2020-11-26Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
#10 | 2020-03-12Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#11 | 2020-02-13Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
#12 | 2019-12-19Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#13 | 2018-12-06Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals
#14 | 2018-10-25Method of treating macular degeneration using botulinum toxin-based pharmaceuticals
#15 | 2018-10-18Method of treating macular degeneration using botulinum toxin-based pharmaceuticals
#16 | 2018-06-14Method of treating macular degeneration using botulinum toxin-based pharmaceuticals
#17 | 2017-11-23Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#18 | 2017-11-09Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#19 | 2017-09-07Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#20 | 2017-06-15Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#21 | 2017-06-15Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#22 | 2017-05-25Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#23 | 2016-02-25Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#24 | 2016-02-18Botulinum toxin and the treatment of primary disorders of mood and affect
#25 | 2015-10-22Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#26 | 2015-09-17Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#27 | 2015-05-14Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#28 | 2015-03-26Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#29 | 2015-03-26Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
#30 | 2014-10-23High-Potency Botulinum Toxin Formulations
#31 | 2010-11-04High-potency botulinum toxin formulations
#32 | 2010-11-04Use of botulinum toxin for the treatment of chronic facial pain
#33 | 2009-06-11Anti-inflammatory topical botulinum toxin composition
#34 | 2009-05-26Chemodenervating pharmaceutical as anti-inflammatory agent
#35 | 2007-01-11Botulinum toxin and the treatment of primary disorders of mood and affect
#36 | 2006-08-17High-potency botulinum toxin formulations
#37 | 2006-07-06Compositions, methods and devices for preparing less painful Botulinum toxin formulations
#38 | 2005-09-22Methods of using toxin for the treatment of hypervolemic lip deformity (lip ectropion)
945613 ⎘